(NASDAQ: HOOK) Hookipa Pharma's forecast annual revenue growth rate of -20.07% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.
Hookipa Pharma's revenue in 2024 is $20,129,000.On average, 2 Wall Street analysts forecast HOOK's revenue for 2024 to be $2,110,111,032, with the lowest HOOK revenue forecast at $1,800,891,947, and the highest HOOK revenue forecast at $2,419,330,116. On average, 2 Wall Street analysts forecast HOOK's revenue for 2025 to be $979,606,059, with the lowest HOOK revenue forecast at $781,705,845, and the highest HOOK revenue forecast at $1,177,506,273.
In 2026, HOOK is forecast to generate $1,484,251,605 in revenue, with the lowest revenue forecast at $1,484,251,605 and the highest revenue forecast at $1,484,251,605.